These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
96 related articles for article (PubMed ID: 8113010)
1. Vascular wall von Willebrand factor in human diabetic retinopathy. Boeri D; Cagliero E; Podestá F; Lorenzi M Invest Ophthalmol Vis Sci; 1994 Feb; 35(2):600-7. PubMed ID: 8113010 [TBL] [Abstract][Full Text] [Related]
2. Fibronectin overexpression in retinal microvessels of patients with diabetes. Roy S; Cagliero E; Lorenzi M Invest Ophthalmol Vis Sci; 1996 Feb; 37(2):258-66. PubMed ID: 8603829 [TBL] [Abstract][Full Text] [Related]
3. Vascular endothelial growth factor and vascular permeability changes in human diabetic retinopathy. Mathews MK; Merges C; McLeod DS; Lutty GA Invest Ophthalmol Vis Sci; 1997 Dec; 38(13):2729-41. PubMed ID: 9418725 [TBL] [Abstract][Full Text] [Related]
4. Early increase precedes a depletion of endothelin-1 but not of von Willebrand factor in cutaneous microvessels of diabetic patients. A quantitative immunohistochemical study. Properzi G; Terenghi G; Gu XH; Poccia G; Pasqua R; Francavilla S; Polak JM J Pathol; 1995 Feb; 175(2):243-52. PubMed ID: 7738721 [TBL] [Abstract][Full Text] [Related]
5. Measurement of gene expression in human retinal microvessels by solution hybridization. Cagliero E; Grant MB; Lorenzi M Invest Ophthalmol Vis Sci; 1991 Apr; 32(5):1439-45. PubMed ID: 1707859 [TBL] [Abstract][Full Text] [Related]
6. Diabetes is associated with a high incidence of endothelial-binding antibodies which do not correlate with retinopathy, von Willebrand factor, angiotensin-converting enzyme or C-reactive protein. Petty RG; Pottinger BE; Greenwood RM; Pearson JD; Mahler RF Diabetes Res; 1991 Jul; 17(3):115-23. PubMed ID: 1668655 [TBL] [Abstract][Full Text] [Related]
7. Measurement of von Willebrand factor-specific mRNA and release and storage of von Willebrand factor from endothelial cells of dogs with type-I von Willebrand's disease. Meinkoth JH; Meyers KM Am J Vet Res; 1995 Dec; 56(12):1577-85. PubMed ID: 8599517 [TBL] [Abstract][Full Text] [Related]
11. Vascular endothelial growth factor is present in glial cells of the retina and optic nerve of human subjects with nonproliferative diabetic retinopathy. Amin RH; Frank RN; Kennedy A; Eliott D; Puklin JE; Abrams GW Invest Ophthalmol Vis Sci; 1997 Jan; 38(1):36-47. PubMed ID: 9008628 [TBL] [Abstract][Full Text] [Related]
12. Von Willebrand factor in type 1 diabetes: its production and coronary artery calcification. Chan NN; Fuller JH; Rubens M; Colhoun HM Med Sci Monit; 2003 Jul; 9(7):CR297-303. PubMed ID: 12883448 [TBL] [Abstract][Full Text] [Related]
13. Altered expression patterns of VEGF receptors in human diabetic retina and in experimental VEGF-induced retinopathy in monkey. Witmer AN; Blaauwgeers HG; Weich HA; Alitalo K; Vrensen GF; Schlingemann RO Invest Ophthalmol Vis Sci; 2002 Mar; 43(3):849-57. PubMed ID: 11867607 [TBL] [Abstract][Full Text] [Related]
14. von Willebrand factor in diabetic retinopathy. Abayomi EA; Miller E; Paton RC Cent Afr J Med; 1996 Jul; 42(7):205-6. PubMed ID: 8936786 [TBL] [Abstract][Full Text] [Related]
15. Differential distribution of von Willebrand factor in canine vascular endothelium. Smith JM; Meinkoth JH; Hochstatter T; Meyers KM Am J Vet Res; 1996 May; 57(5):750-5. PubMed ID: 8723894 [TBL] [Abstract][Full Text] [Related]
16. Retinal capillary pericyte apoptosis in early human diabetic retinopathy. Li W; Yanoff M; Liu X; Ye X Chin Med J (Engl); 1997 Sep; 110(9):659-63. PubMed ID: 9642318 [TBL] [Abstract][Full Text] [Related]
17. Altered expression of retinal occludin and glial fibrillary acidic protein in experimental diabetes. The Penn State Retina Research Group. Barber AJ; Antonetti DA; Gardner TW Invest Ophthalmol Vis Sci; 2000 Oct; 41(11):3561-8. PubMed ID: 11006253 [TBL] [Abstract][Full Text] [Related]
18. Endothelial dysfunction and low-grade inflammation and the progression of retinopathy in Type 2 diabetes. Spijkerman AM; Gall MA; Tarnow L; Twisk JW; Lauritzen E; Lund-Andersen H; Emeis J; Parving HH; Stehouwer CD Diabet Med; 2007 Sep; 24(9):969-76. PubMed ID: 17593241 [TBL] [Abstract][Full Text] [Related]
19. von Willebrand factor (vWf) as a plasma marker of endothelial activation in diabetes: improved reliability with parallel determination of the vWf propeptide (vWf:AgII). Vischer UM; Emeis JJ; Bilo HJ; Stehouwer CD; Thomsen C; Rasmussen O; Hermansen K; Wollheim CB; Ingerslev J Thromb Haemost; 1998 Dec; 80(6):1002-7. PubMed ID: 9869174 [TBL] [Abstract][Full Text] [Related]
20. Transcriptional expression of tissue factor pathway inhibitor, thrombomodulin and von Willebrand factor in normal human tissues. Bajaj MS; Kuppuswamy MN; Manepalli AN; Bajaj SP Thromb Haemost; 1999 Sep; 82(3):1047-52. PubMed ID: 10494762 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]